J&J’s Lung Cancer Drug Set a Survival Benchmark. Here Is What Investors Are Missing.
September 16, 2026 J&J’s Lung Cancer Drug Set a Survival Benchmark PAPILLON is historic for...
Waystar Is Down Big. Now It Wants Out.
Waystar hired Evercore to explore a sale, two years after its IPO, with EQT still holding about 13% and analysts…
#1 Power Grid Stock Right Now
September 15, 2026 Bonus Content: Microsoft’s $678 Billion Backlog vs. a 5% Treasury A note...
Bitcoin Gave Back 3% Overnight. Senate Vote at 2:15 Explains Why.
Polymarket odds for the CLARITY Act in 2026 fell to about 18%, and the 60-vote procedural test is this afternoon.
Wall Street Has a Blunt New Name for What’s Happening to the Dollar
A note from our friends at America\’s Gold Company_AGC(ad) Wall Street Has a Blunt New...
Copper’s Record Run Is Cooling. What That Tells Gold Investors.
September 15, 2026 Warehouse deliveries are arriving and the physical squeeze is easing Comex copper...
OpenAI Stays Private. Anthropic Heads to Nasdaq. What That Split Means for AI Investors.
Two of the largest capital decisions in tech history are moving in opposite directions, and the divergence tells you something…
Gold Is Rising. Early Stories Usually Move First
September 15, 2026 Bonus Content: ExxonMobil’s 20th Angola Find Changes the Math A note from...
APH’s Order Book Hit $10.7B. Q3 Earnings Are Oct. 28.
A 2-for-1 split, a 1.23 book-to-bill, and IT datacom growing 63% organically keep Amphenol at the center of AI infrastructure…
D.C. Wants Experienced Drone Makers. This One Has 25 Years Behind It.
A note from our friends at i2i Marketing Group(ad) Wall Street loves a new story....